增加的NSD3基因组甲基化活性导致状细胞肺癌
Gang Yuan1, Natasha M Flores2, Simone Hausmann2
1Department of Biology, Stanford University, Stanford, CA, USA.
Nature
|February 4, 2021
概括
基因组甲基转移酶NSD3是由8p11-12安普利康驱动的肺状细胞癌 (LUSC) 的关键驱动因素. 向NSD3,而不是FGFR1,在LUSC中显示出治疗潜力,特别是在代体抑制剂中.
科学领域:
- 癌症学
- 遗传学
- 表观遗传学
背景情况:
- 在肺状细胞癌 (LUSC) 中,8p11-12染色体区域的放大很常见.
- FGFR1被认为是主要的驱动因素,但在临床试验中,FGFR1抑制失败了.
- 作为一个潜在的驱动因素,NSD3是位于8p11-12amplicon中的 histone H3 lysine 36甲基转移酶.
研究的目的:
- 在LUSC的8p11-12 amplicon中识别瘤发生的关键驱动因素.
- 研究NSD3在LUSC发展中的作用及其治疗影响.
- 探索NSD3依赖的LUSC的治疗脆弱性.
主要方法:
- 在LUSC中对NSD3表达和基因放大的相关性分析.
- 在体外和体内研究涉及NSD3剥离和LUSC模型中的变异表达.
- 对NSD3催化活性进行结构动态分析.
- 评估NSD3在人类细胞转化和异种移植生长中的作用.
- 在NSD3调节的LUSC异种移植中评估代蛋白抑制.
主要成果:
- 与FGFR1不同的是,NSD3表达与LUSC中的基因放大有很强的相关性.
- 在小鼠模型中,NSD3的切除,而不是FGFR1的切除,降低了瘤生长和改善了生存率.
- 一种与LUSC相关的变体NSD3 (T1232A) 呈现出增强的催化活性,加速瘤形成并降低存活率.
- NSD3 ((T1232A) 重新编程染色体,促进致癌基因表达.
- 在患者衍生的异种移植中,NSD3 枯竭减弱了瘤生长,而NSD3 调节的异种移植对主体抑制敏感.
结论:
- NSD3被确定为与8p11-12片相关的LUSC的主要致癌驱动因素.
- NSD3的催化活性及其变体NSD3 (T1232A) 对LUSC瘤发生至关重要.
- 由于对NSD3的依赖,LUSC在治疗上容易受到主体抑制的影响.
相关概念视频
Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Epigenetic Regulation
3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.4K
Epigenetic Regulation
32.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.1K
Histone Variants at the Centromere
4.7K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.7K


